SIRT1-mediated signaling pathways have been shown to attenuate key pathological features of MASH, including hepatic steatosis, inflammation, fibrosis, and cellular senescence (Cao et al., 2013; Hua et al., 2021). Here, SIRT1 is linked to fatty liver disease.